Source:http://linkedlifedata.com/resource/pubmed/id/11121715
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
11
|
pubmed:dateCreated |
2000-12-27
|
pubmed:abstractText |
3-Nitrotyrosine (3NT) is used as a biomarker of nitrative pathology caused by peroxynitrite (PN), myeloperoxidase (MPO)-, and/or eosinophil peroxidase (EPO)-dependent nitrite oxidation. 3NT measurements in biological materials are usually based on either antibody staining, HPLC detection, or GC detection methodologies. In this report, a procedure is described for the measurement of 3NT and tyrosine (TYR) by LC-MS/MS that is simple, direct, and sensitive. Though highly specialized in its use as an assay, LC-MS/MS technology is available in many research centers in academia and industry. The critical assay for 3NT was linear below 100 ng/ml and the limit of detection was below 100 pg/ml. Regarding protein digested samples, we found that MRM was most selective with 133.1 m/z as the daughter ion. In comparison, LC-ECD was 100 times less sensitive. Basal levels of 3NT in extracted digests of rat brain homogenate were easily detected by LC-MS/MS, but were below detection by LC-ECD. The LC-MS/MS assay was used to detect 3NT in rat brain homogenate that was filtered through a 180 micron nylon mesh. Three fractions were collected and examined by phase contrast microscopy. The mass ratio (3NT/TYR) of 3NT in fractions of large vessel enrichment, microvessel enrichment, and vessel depletion was 0.6 ng/mg, 1.2 ng/mg, and 0.2 ng/mg, respectively. Ultimately, we found that the basal 3NT/TYR mass ratio as determined by LC-MS/MS was six times greater in microvessel-enriched brain tissue vs. tissue devoid of microvessels.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0891-5849
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
29
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1085-95
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11121715-Animals,
pubmed-meshheading:11121715-Brain,
pubmed-meshheading:11121715-Chromatography, Liquid,
pubmed-meshheading:11121715-Mass Spectrometry,
pubmed-meshheading:11121715-Microcirculation,
pubmed-meshheading:11121715-Microscopy, Phase-Contrast,
pubmed-meshheading:11121715-Nitrates,
pubmed-meshheading:11121715-Rats,
pubmed-meshheading:11121715-Rats, Wistar,
pubmed-meshheading:11121715-Sensitivity and Specificity,
pubmed-meshheading:11121715-Tyrosine
|
pubmed:year |
2000
|
pubmed:articleTitle |
LC-MS/MS detection of peroxynitrite-derived 3-nitrotyrosine in rat microvessels.
|
pubmed:affiliation |
Neuroscience Therapeutics, Pfizer Global Research and Development, Ann Arbor, MI 48105, USA. john.althaus@wl.com
|
pubmed:publicationType |
Journal Article
|